These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19548223)

  • 1. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs.
    Jarernsiripornkul N; Krska J; Pongmanachai M; Nasritha N
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):837-41. PubMed ID: 19548223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
    Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hospital and community pharmacists in pharmacovigilance.
    van Grootheest AC; de Jong-van den Berg LT
    Res Social Adm Pharm; 2005 Mar; 1(1):126-33. PubMed ID: 17138470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs.
    Jarernsiripornkul N; Kakaew W; Loalukkana W; Krska J
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):240-5. PubMed ID: 19148880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' role in reporting adverse drug reactions in an international perspective.
    van Grootheest K; Olsson S; Couper M; de Jong-van den Berg L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):457-64. PubMed ID: 15269929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions.
    Tyler LS; Nickman NA
    Am J Hosp Pharm; 1992 Apr; 49(4):845-50. PubMed ID: 1595720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary program for detecting and evaluating adverse drug reactions.
    Keith MR; Bellanger-McCleery RA; Fuchs JE
    Am J Hosp Pharm; 1989 Sep; 46(9):1809-12. PubMed ID: 2801715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand.
    Phueanpinit P; Jarernsiripornkul N; Pongwecharak J; Krska J
    Int J Clin Pharm; 2014 Dec; 36(6):1205-12. PubMed ID: 25288144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong.
    Lee KK; Chan TY; Raymond K; Critchley JA
    Ann Pharmacother; 1994 Dec; 28(12):1400-3. PubMed ID: 7696734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia.
    Aziz Z; Siang TC; Badarudin NS
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):223-8. PubMed ID: 16947117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
    Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
    Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist-managed monitoring of adverse reactions to contrast media.
    Damiani DR; Swanson DP
    Am J Hosp Pharm; 1994 Feb; 51(3):358-63. PubMed ID: 8160688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.
    Bond CA; Raehl CL
    Pharmacotherapy; 2006 Jun; 26(6):735-47. PubMed ID: 16716127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.